Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Nature Neuroscience|October 31, 2002
NMDA receptor pathways as drug targetsJohn A Kemp, Ruth M McKernanCurrent Opinion in Pharmacology|December 27, 2005
Glutamate- and GABA-based CNS therapeuticsAlan C Foster, John A KempPsychopharmacology|February 26, 2005
Ionotropic and metabotropic glutamate receptor structure and pharmacologyJames N C Kew, John A KempJournal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 17, 2004
Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult ratsRamanjit Gill, John A Kemp, Caroline Sabin, et al.Neuropharmacology|September 6, 2002
Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- miceJames N C Kew, Marie-Claire Pflimlin, John A Kemp, et al.Psychopharmacology|March 11, 2005
Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the ratGuy A Higgins, Theresa M Ballard, Michel Enderlin, et al.Psychopharmacology|February 27, 2004
Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibitionWill Spooren, Cedric Mombereau, Martine Maco, et al.Experimental Neurology|April 15, 2004
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's diseasePeter-Andreas Löschmann, Carmen De Groote, Lance Smith, et al.The Journal of Pharmacology and Experimental Therapeutics|October 10, 2003
Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocketPari Malherbe, Vincent Mutel, Clemens Broger, et al.Acta Neurobiologiae Experimentalis|January 18, 2017
Age-dependent concomitant changes in synaptic dysfunction and GABAergic pathway in the APP/PS1 mouse modelTutu Oyelami, An De Bondt, Ilse Van den Wyngaert, et al.Pageof 3